Equity · Healthcare
BRKRP
Bruker Corporation · NasdaqGS
The line runs $330.69 on 19 May through $426.90 on 14 August, on a scale from $300 to $500. Days the market did not trade hold the previous close, flat.
The chart above plots the price of BRKRP over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 36 sessions over that window: $330.69 on 19 May 2026 through $426.90 on 14 August 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 17, 2026
Filings 3 sets
BRKRP reported financials
BRKRP reported revenue of $3.4B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$8.6M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
BRKRP earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
BRKRP institutional holders
3 of the 45 institutional funds we track reported a BRKRP position for the quarter ended 30 Jun 2026 — a combined $131.5M; the latest of those filings landed 14 Aug 2026.
Source: SEC EDGAR 13F filings